eClinical Solutions Market

eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026

Report Code: HIT 2208 Sep, 2021, by marketsandmarkets.com

[234 Pages Report] The global eClinical Solutions market is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech companies are some of the major driving factors for the global eClinical solutions market.

eClinical Solutions Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the eClinical solutions Market

The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have acknowledged that due to COVID-19 there will be protocol deviations in the traditional process of clinical trials and hence, most of the clinical trial protocol modifications now being considered involve conducting some elements of the clinical trial life cycle remotely. The clinical trials market is shifting toward digital ways of working, and the COVID-19 outbreak is likely to both accelerate this trend and drive long-term changes to historically accepted trial management norms. If virtual and remote working modes prove to be sustainable methods of conducting a trial, it can be a great opportunity for all eClinical solutions providers. They will then require comprehensive trial platforms that address the changing unmet needs and evolve their product portfolios to cater to the specific needs of the modern clinical trial.

eClinical solutions market Dynamics

Drivers: Growing adoption of novel software solutions in clinical research

It takes ~13 years and overall investment of up to USD 1.3 billion (~USD 146 million per year) to commercialize a successful drug candidate; this includes initial drug screening, product synthesis, preclinical and clinical studies, as well as regulatory filing and approval. Therefore, researchers increasingly prefer innovative eClinical solutions that offer improved efficiency of clinical trials, enhance site performance, and streamline research workload with higher cost efficiency compared to conventional methodologies. These software solutions allow pharmaceutical companies as well as independent researchers to compare the operating characteristics of the software design options; model, forecast, and track clinical trial enrolment; and identify the procedural bottlenecks associated with clinical trials. The procedural and operational benefits offered by eClinical solutions are resulting in significant growth in the adoption of these solutions among CROs independent researchers, as well as pharmaceutical, medical device, and biotechnology companies for their clinical research programs.

Restrains: High implementation costs associated with eClinical solutions

eClinical solutions help researchers to efficiently organize, standardize, and manage their clinical research data and metadata during their research lifecycle. A number of integrated eClinical solutions (such as CTMS and CDMS) provide end-to-end solutions to clinical researchers for all clinical trial processes. However, these software solutions are expensive and priced at a premium. The installation and maintenance of eClinical solutions costs approximately USD 2 million with additional costs for technical assistance for cloud-based solutions. The high costs associated with advanced eClinical software solutions are expected to restrain their optimal adoption among price-sensitive and small-sized end users, including pharma-biotech companies, independent researchers, and CROs.

Opportunities: Increasing clinical research activities in emerging

Asian countries are emerging as key outsourcing destinations for clinical trials primarily due to the presence of a large and genetically diverse population, high disease prevalence, and availability of low-cost outsourcing services. A significant number of clinical trials are outsourced to CROs based in China and India. According to a 2019 database study by WHO, 125,918 clinical trials were conducted in Asia; this accounted for about 28.5% of all registered clinical trials. The growing number of pharmaceutical companies in developing Asian countries such as China, India, Taiwan, and Korea has also opened up growth opportunities for the eClinical solutions market in this region. China is the key emerging market for pharma and biopharmaceutical companies. According to a survey, more than 1,000 clinical trials were conducted in 2019 in China as compared to 339 trials in 2015. Phase I trials top the list each year, amounting to 486 trials in 2019. Funding support from governments, private entities, and other non-profit organizations in the region is also expected to aid market growth in the next 5 to 10 years.

Challenge: Patient privacy issues

Data integration raises the issue of patient privacy; the increase in the number of databases shared among research institutions, CROs, partners, and software companies increases the risk of data leakage. The 2009 Health Information Technology for Economic and Clinical Health Act (HITECH Act) states that the covered entities must protect individual health records and other identifiable health information by acquiring appropriate safeguards to protect privacy. The application of electronic tools for patient databases increases concerns about privacy issues regarding patient records; this creates a key challenge for pharmaceutical enterprises in terms of complying with privacy policies while using eClinical software solutions.

North America To Witness Significant Growth From 2021 To 2026

North America commanded the largest share of the eClinical solutions market in 2020. Increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, and growth in the number of partnerships for new drug development are further stimulating the demand for eClinical solutions in this region.

eClinical Solutions Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Oracle Corporation (US), Medidata Solutions, Inc. (US), Parexel International Corporation (US), BioClinica, Inc. (US), Signant Health (US), Datatrak International, Inc. (US), ERT (US), eClinical Solutions, Inc. (US), MaxisIT Inc. (US), Bio-Optronics, Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems, Inc. (US) are key players in eClinical solutions Market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

By Product, By Delivery mode, By Clinical trials phases, By End User & By Region

Geographies covered

North America, Europe, Asia Pacific, ROW

Companies covered

The major market players are Oracle Corporation (US), Medidata Solutions, Inc. (US), Parexel International Corporation (US), BioClinica, Inc. (US), Signant Health (US), Datatrak International, Inc. (US), ERT (US), eClinical Solutions, Inc. (US), MaxisIT Inc. (US), Bio-Optronics, Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems, Inc. (US)  Major 25 companies covered

By Product

  • CDMS/EDC Solutions
  • CTMS Solutions
  • eCOA Solutions
  • RTMS Solutions
  • Safety Solutions
  • Analytics and Reporting Platforms
  • Integration Platforms
  • eTMF
  • Others

By Delivery Mode

  • Web-based (on-demand) Model
  • Licensed enterprise (on-premise) Model
  • Cloud-based (saas) Model
  • By Clinical trials Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Consulting Service Companies
  • Medical Device Manufacturers
  • Hospitals
  • Academic Research Institutions

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • RoW

Recent Developments

  • In May 2021, The Tasmanian Government partnered with Oracle Corporations to use its health management system to manage the Covid-19 vaccination program.
  • In April 2021, Signant Health announced the launch of electronic informed consent offerings and enhanced capabilities with the new release of SmartSignals™ eConsent. Key product functionality updates and tiered license options provide sponsors with more control over obtaining electronic informed consent and reconsent for any study design.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 33)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.2 MARKETS COVERED
           1.2.3 GEOGRAPHIC SCOPE
           1.2.4 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 MAJOR MARKET STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH APPROACH
    2.2 RESEARCH METHODOLOGY DESIGN
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION: ECLINICAL SOLUTIONS MARKET
          FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION
          FIGURE 6 REVENUE ANALYSIS OF TOP 3 PUBLIC COMPANIES: ECLINICAL SOLUTIONS MARKET (2020)
          FIGURE 7 BOTTOM-UP APPROACH
          FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ECLINICAL SOLUTIONS MARKET (2021–2026)
          FIGURE 10 TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    2.5 MARKET SHARE ESTIMATION
    2.6 ASSUMPTIONS FOR THE STUDY
    2.7 LIMITATIONS
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT
          TABLE 1 RISK ASSESSMENT: ECLINICAL SOLUTIONS MARKET

3 EXECUTIVE SUMMARY (Page No. - 52)
    FIGURE 12 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2021 VS. 2026 (USD MILLION)
    FIGURE 14 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2021 VS. 2026 (USD MILLION)
    FIGURE 15 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 16 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2020 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 57)
    4.1 ECLINICAL SOLUTIONS: MARKET OVERVIEW
          FIGURE 17 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING FORECAST PERIOD
    4.2 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE AND COUNTRY (2020)
          FIGURE 18 WEB-HOSTED DELIVERY MODE DOMINATED ECLINICAL SOLUTIONS MARKET IN 2020
    4.3 ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2021 VS. 2026)
          FIGURE 19 PHASE III CLINICAL TRIALS TO DOMINATE GLOBAL ECLINICAL SOLUTIONS MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 59)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 20 GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 MAJOR MARKET DRIVERS
                    5.2.1.1 Increasing operational costs and regulatory requirements associated with clinical research studies
                    5.2.1.2 Growing adoption of novel software solutions in clinical research
                    5.2.1.3 Increased government funding and grants to support clinical trials
                    5.2.1.4 Need for improved data standardization
                    5.2.1.5 Increasing R&D expenditure on drug development pipeline by pharma-biotech companies
                    5.2.1.6 Growing customer base for eClinical solutions
                                TABLE 2 US: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED BETWEEN 2011 & 2015
           5.2.2 MAJOR MARKET RESTRAINTS
                    5.2.2.1 High implementation costs associated with eClinical solutions
                    5.2.2.2 Dearth of skilled professionals to operate eClinical solutions
                    5.2.2.3 Limited awareness of advantages of eClinical solutions among researchers
           5.2.3 KEY GROWTH OPPORTUNITIES
                    5.2.3.1 Increasing clinical research activities in emerging Asian countries
                    5.2.3.2 Greater outsourcing of clinical trial processes to CROs
                    5.2.3.3 Rising number of clinical trials in emerging countries
                    5.2.3.4 Shift from manual data interpretation to real-time data analysis during clinical studies
           5.2.4 MAJOR MARKET CHALLENGES
                    5.2.4.1 Limited adoption of eClinical solutions in developing nations
                    5.2.4.2 Concerns about software reliability
                    5.2.4.3 Patient privacy issues
    5.3 IMPACT OF COVID-19 ON THE ECLINICAL SOLUTIONS MARKET
    5.4 ECOSYSTEM ANALYSIS OF ECLINICAL SOLUTIONS MARKET
          FIGURE 21 ECOSYSTEM ANALYSIS OF ECLINICAL SOLUTIONS MARKET
    5.5 CASE STUDIES
           5.5.1 YORK TEACHING HOSPITAL SPEEDS UP DATA CAPTURE PROCESS DURING PHASE III CLINICAL STUDY
           5.5.2 LSHTM AND MENAFRICAR USE DATA CAPTURE SOFTWARE TO STUDY MENINGOCOCCAL CARRIAGE IN AFRICAN MENINGITIS BELT
           5.5.3 CLINICAL TRIALS GROUP AT UCL USES EDC SYSTEM TO CAPTURE AND VERIFY PATIENT FEEDBACK
    5.6 VALUE CHAIN ANALYSIS
          FIGURE 22 ECLINICAL SOLUTIONS : VALUE CHAIN
    5.7 PORTER’S FIVE FORCES ANALYSIS
          TABLE 3 HIGH CAPITAL INVESTMENTS TO RESTRICT ENTRY OF NEW PLAYERS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY

6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT (Page No. - 70)
    6.1 INTRODUCTION
          TABLE 4 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
          TABLE 5 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
    6.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
          TABLE 6 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 7 NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
          TABLE 8 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 9 NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 CLINICAL TRIAL MANAGEMENT SYSTEMS
          TABLE 10 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 11 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
          TABLE 12 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 13 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.4 CLINICAL ANALYTICS PLATFORMS
          TABLE 14 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 15 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
          TABLE 16 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 17 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.5 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
          TABLE 18 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 19 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
          TABLE 20 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 21 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.6 CLINICAL DATA INTEGRATION PLATFORMS
          TABLE 22 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 23 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
          TABLE 24 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 25 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.7 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
          TABLE 26 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 27 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
          TABLE 28 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 29 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.8 SAFETY SOLUTIONS
          TABLE 30 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 31 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
          TABLE 32 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 33 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.9 ELECTRONIC TRIAL MASTER FILE SYSTEMS
          TABLE 34 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 35 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
          TABLE 36 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 37 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.10 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
           TABLE 38 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
           TABLE 39 NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015–2018 (USD MILLION)
           TABLE 40 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
           TABLE 41 NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
    6.11 OTHER ECLINICAL SOLUTIONS
           TABLE 42 GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
           TABLE 43 NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
           TABLE 44 GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
           TABLE 45 NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)

7 ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE (Page No. - 90)
    7.1 INTRODUCTION
          TABLE 46 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2015–2018 (USD MILLION)
          TABLE 47 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)
    7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
          TABLE 48 WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 49 WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
    7.3 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS
          TABLE 50 LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 51 LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
    7.4 CLOUD-BASED (SAAS) SOLUTIONS
          TABLE 52 CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
          TABLE 53 CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)

8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE (Page No. - 96)
    8.1 INTRODUCTION
          FIGURE 23 PHASE III TRIALS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
          TABLE 54 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
          TABLE 55 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
    8.2 PHASE I CLINICAL TRIALS
          TABLE 56 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2015–2018 (USD MILLION)
          TABLE 57 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2019–2026 (USD MILLION)
    8.3 PHASE II CLINICAL TRIALS
          TABLE 58 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2015–2018 (USD MILLION)
          TABLE 59 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2019–2026 (USD MILLION)
    8.4 PHASE III CLINICAL TRIALS
          TABLE 60 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2015–2018 (USD MILLION)
          TABLE 61 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2019–2026 (USD MILLION)
    8.5 PHASE IV CLINICAL TRIALS
          TABLE 62 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2015–2018 (USD MILLION)
          TABLE 63 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2019–2026 (USD MILLION)

9 ECLINICAL SOLUTIONS MARKET, BY END USER (Page No. - 103)
    9.1 INTRODUCTION
          FIGURE 24 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2020)
          TABLE 64 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
          TABLE 65 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
    9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
          TABLE 66 ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015–2018 (USD MILLION)
          TABLE 67 ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2019–2026 (USD MILLION)
    9.3 CONTRACT RESEARCH ORGANIZATIONS
          TABLE 68 KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011–2015)
          TABLE 69 ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION, 2015–2018 (USD MILLION)
          TABLE 70 ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION, 2019–2026 (USD MILLION)
    9.4 CONSULTING SERVICE COMPANIES
          TABLE 71 ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2015–2018 (USD MILLION)
          TABLE 72 ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2019–2026 (USD MILLION)
    9.5 MEDICAL DEVICE MANUFACTURERS
          TABLE 73 ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2015–2018 (USD MILLION)
          TABLE 74 ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2019–2026 (USD MILLION)
    9.6 HOSPITALS
          TABLE 75 ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2015–2018 (USD MILLION)
          TABLE 76 ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
    9.7 ACADEMIC RESEARCH INSTITUTES
          TABLE 77 ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015–2018 (USD MILLION)
          TABLE 78 ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)

10 ECLINICAL SOLUTIONS MARKET, BY REGION (Page No. - 113)
     10.1 INTRODUCTION
             FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2021 VS. 2026 (USD MILLION)
             TABLE 79 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)
             TABLE 80 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 26 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT
             TABLE 81 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
             TABLE 82 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 83 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
             TABLE 84 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
             TABLE 85 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
             TABLE 86 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
             TABLE 87 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
             TABLE 88 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
             TABLE 89 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
             TABLE 90 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Availability of government funding for clinical research to drive market growth
                                      TABLE 91 US: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 92 US: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 93 US: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 94 US: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 95 US: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 96 US: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 97 US: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
                                      TABLE 98 US: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Government support to contribute to market growth
                                      TABLE 99 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 100 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 101 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 102 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 103 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 104 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 105 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
                                      TABLE 106 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
     10.3 EUROPE
             FIGURE 27 EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT
             TABLE 107 EMA-APPROVED BIOSIMILARS
             TABLE 108 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
             TABLE 109 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 110 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
             TABLE 111 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
             TABLE 112 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
             TABLE 113 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
             TABLE 114 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
             TABLE 115 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
             TABLE 116 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION)
             TABLE 117 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Increasing R&D investments and initiatives to boost market growth
                                      TABLE 118 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 119 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 120 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 121 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 122 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 123 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 124 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION)
                                      TABLE 125 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Favorable R&D scenario to boost software adoption
                                      TABLE 126 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 127 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 128 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 129 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 130 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 131 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 132 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION)
                                      TABLE 133 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 High number of oncology clinical trials to drive market growth
                                      TABLE 134 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 135 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 136 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 137 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 138 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 139 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 140 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION)
                                      TABLE 141 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Low drug approval times drive growing adoption of eClinical solutions
                                      TABLE 142 NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY, 2017
                                      TABLE 143 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 144 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 145 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 146 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 147 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 148 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 149 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION)
                                      TABLE 150 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Rising R&D expenditure to propel market growth
                                      TABLE 151 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 152 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 153 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 154 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 155 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 156 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 157 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION)
                                      TABLE 158 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.3.6 REST OF EUROPE
                       TABLE 159 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                       TABLE 160 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                       TABLE 161 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                       TABLE 162 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                       TABLE 163 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                       TABLE 164 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                       TABLE 165 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION)
                       TABLE 166 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
     10.4 ASIA-PACIFIC
             FIGURE 28 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT
             TABLE 167 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)
             TABLE 168 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 169 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
             TABLE 170 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
             TABLE 171 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
             TABLE 172 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
             TABLE 173 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
             TABLE 174 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
             TABLE 175 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
             TABLE 176 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Low cost of clinical trials and large pharmaceutical R&D base to drive market growth
                                      TABLE 177 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 178 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 179 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 180 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 181 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 182 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 183 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
                                      TABLE 184 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Stringent regulatory scenario to restrain market growth
                                      TABLE 185 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 186 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 187 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 188 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 189 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 190 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 191 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
                                      TABLE 192 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Favorable pharmaceutical R&D scenario to drive software adoption
                                      TABLE 193 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                                      TABLE 194 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                                      TABLE 195 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                                      TABLE 196 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                                      TABLE 197 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                                      TABLE 198 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                                      TABLE 199 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
                                      TABLE 200 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                       TABLE 201 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
                       TABLE 202 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
                       TABLE 203 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
                       TABLE 204 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
                       TABLE 205 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
                       TABLE 206 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
                       TABLE 207 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
                       TABLE 208 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
     10.5 REST OF THE WORLD
             FIGURE 29 ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT
             TABLE 209 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)
             TABLE 210 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
             TABLE 211 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)
             TABLE 212 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)
             TABLE 213 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)
             TABLE 214 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)
             TABLE 215 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)
             TABLE 216 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 181)
     11.1 INTRODUCTION
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
             FIGURE 30 ECLINICAL SOLUTIONS MARKET: STRATEGIES ADOPTED
     11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
             FIGURE 31 KEY PLAYERS IN ECLINICAL SOLUTIONS MARKET
     11.4 MARKET SHARE ANALYSIS
             FIGURE 32 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2020
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                       FIGURE 33 ECLINICAL SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2020
     11.6 ECLINICAL SOLUTIONS MARKET: SME EVALUATION
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                       FIGURE 34 ECLINICAL SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR SMES, 2020
     11.7 COMPETITIVE BENCHMARKING
             11.7.1 COMPANY SERVICE FOOTPRINT (25 COMPANIES)
                       FIGURE 35 COMPANY PORTFOLIO FOOTPRINT: ECLINICAL SOLUTIONS MARKET
                       TABLE 217 COMPANY REGION FOOTPRINT (25 COMPANIES)
     11.8 COMPETITIVE SITUATIONS AND TRENDS
             11.8.1 PRODUCT/SERVICE LAUNCHES
                       TABLE 218 PRODUCT/SERVICE LAUNCHES (2018 TO 2021)
             11.8.2 DEALS
                       TABLE 219 DEALS
                       TABLE 220 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 195)
(Business Overview, Products & services Offered, Recent Developments, and Right to win)*
     12.1 KEY PLAYERS
             12.1.1 ORACLE CORPORATION.
                       TABLE 221 ORACLE CORPORATION: BUSINESS OVERVIEW
                       FIGURE 36 ORACLE CORPORATION: COMPANY SNAPSHOT (2020)
             12.1.2 DASSAULT SYSTΘMES
                       TABLE 222 DASSAULT SYSTΘMES: BUSINESS OVERVIEW
                       FIGURE 37 DASSAULT SYSTΘMES: COMPANY SNAPSHOT (2020)
             12.1.3 PAREXEL INTERNATIONAL CORPORATION
                       TABLE 223 PAREXEL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
             12.1.4 BIOCLINICA, INC. (SUBSIDIARY OF CINVEN)
                       TABLE 224 BIOCLINICA : BUSINESS OVERVIEW
             12.1.5 DATATRAK INTERNATIONAL, INC.
                       TABLE 225 DATATRAK INTERNATIONAL, INC: BUSINESS OVERVIEW
                       FIGURE 38 DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT (2020)
             12.1.6 SIGNANT HEALTH (CRF HEALTH)
                       TABLE 226 SIGNANT HEALTH : BUSINESS OVERVIEW
             12.1.7 ERT CLINICAL
                       TABLE 227 NELSON LABORATORIES: BUSINESS OVERVIEW
             12.1.8 MAXISIT INC.
                       TABLE 228 MAXISIT INC.: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS
             12.2.1 4G CLINICAL
             12.2.2 ECLINICAL SOLUTIONS LLC
             12.2.3 VEEVA SYSTEMS
             12.2.4 RESEARCH MANAGER
             12.2.5 SAAMA TECHNOLOGIES
             12.2.6 MEDNET
             12.2.7 ANJU SOFTWARE (PORTFOLIO COMPANY OF ABRY PARTNERS)
             12.2.8 MEDRIO INC
             12.2.9 CASTOR EDC
             12.2.10 CLINPACE CLINICAL RESEARCH
             12.2.11 IBM WATSON HEALTH
             12.2.12 ARIS GLOBAL
             12.2.13 QURETEC. LTD
             12.2.14 OPENCLINICA
             12.2.15 ADVARRA
             12.2.16 REAL TIME SOFTWARE SOLUTIONS
             12.2.17 YPRIME

*Details on Business Overview, Products & services Offered, Recent Developments, and Right to win might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 227)
     13.1 DISCUSSION GUIDE*
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved four major activities in estimating the size of eClinical solutions market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

The secondary research involved the use of widespread secondary sources; publications from government sources such as the ClinicalTrials.gov, National Institutes of Health (NIH), US FDA, WHO, the World Bank, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Eurostat - European Commission; corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; and trade, business, and professional associations.

Secondary research was mainly used to obtain key information about the industry’s total pool of key players, market classification and segmentation according to industry trends, global market trends, and key developments by both public and private organizations in the eClinical solutions market.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the eClinical solutions market. The primary sources from the demand side included hospitals, CROS, consulting service companies, Pharmaceutical companies and academic institutions. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

eClinical Solutions Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Both top-down and bottom-up approaches were used to estimate and validate the total size of eClinical solutions market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides, in the provider, payer, and other industries.

Report Objectives

  • To define, describe, and forecast the eClinical solutions market on the basis of product, delivery mode, clinical trial phase, end user, and region
  • To provide detailed information regarding the major factors influencing growth of the global eClinical solutions market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to their individual growth trends, future prospects, and contributions to the global eClinical solutions market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the global eClinical solutions market with respect to four regions: North America, Europe, Asia-Pacific, and the Rest of the World
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies2 in terms of market developments and growth strategies
  • To track and analyze competitive developments in the eClinical solutions market, such as product launches and product enhancements; agreements, partnerships, and collaborations; as well as mergers and acquisitions

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies in the eClinical solutions market
  • Contract Research Organizations (CROs) Market Segmentation by Clinical Trial Phase
  • Contract research organizations (CROs) market segmentation by clinical trial phase (including Phase I, Phase II, Phase III, and Phase IV clinical trials)

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
COVID-19

Get in-depth analysis of the COVID-19 impact on the eClinical Solutions Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the eClinical Solutions Market

Request For Special Pricing
Report Code
HIT 2208
Published ON
Sep, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the eClinical Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved